(Q33632141)

28 July 2017

1 reference

title

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action (English)

1 reference

28 July 2017

1 reference

Löscher W

1

1 reference

28 July 2017

publication date

1 May 1999

1 reference

28 July 2017

published in

Progress in Neurobiology

1 reference

28 July 2017

volume

58

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

31-59

1 reference

Quantitative structure-anticonvulsant activity relationships of valproic acid, related carboxylic acids and tetrazoles

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Distribution of Unsaturated Metabolites of Valproate in Human and Rat Brain‐Pharmacologic Relevance?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Electrophysiologic analysis of the actions of valproate on pyramidal neurons in the rat hippocampal slice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Sodium valproate induced alterations in monoamine levels in different regions of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of sodium valproate on hypothalamic neurons in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Mechanism of anticonvulsant action of valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

?In vivo? administration of valproate decreases t-[35S]butylbicyclophosphorothionate binding in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Lysergic acid diethylamide antagonizes shaking induced in rats by five chemically different compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Common anticonvulsants inhibit Ca2+ uptake and amino acid neurotransmitter release in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Possible mechanisms of valproate in migraine prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

γ-Aminobutyric acid-ergic analgesia: Implications for γ-aminobutyric acid-ergic therapy for drug addictions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The action of valproate on spontaneous epileptiform activity in the absence of synaptic transmission and on evoked changes in [Ca2+]o and [K+]o in the hippocampal slice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Distribution of valproate across the interface between blood and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Anticonvulsant potency of common antiepileptic drugs in the gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Sodium di-n-propylacetate (valproate) potentiates responses to GABA and muscimol on single central neurones.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Benzodiazepine cross-tolerance in mice extends to sodium valproate.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Central actions of valproic acid in man and in experimental models of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Sodium valproate enhances responses to GABA receptor activation only at high concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

[Structural bases of the teratogenic effects of the antiepileptic valproic acid. 2-n-propyl-4-pentenic acid, the first structural analogue with significantly higher teratogenic action than VPA].

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

On the development of alternative antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The enantioselective teratogenicity of 2-n-propyl-4-pentynoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Strategies for the development of drugs for pharmacoresistant epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The anticonvulsant valproic acid concentrates in the olfactory bulb: selective laminar localization.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Monoamine and GABA metabolism and the anticonvulsant action of DI-n-propylacetate and ethanolamine-O-sulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of valproic acid on serotonin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Cellular compartments of GABA in brain and their relationship to anticonvulsant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Differential effects of n-dipropylacetate and amino-oxyacetic acid on Gm-aminobutyric acid levels in discrete areas of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic Acid: Update on Its Mechanisms of Action

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The mechanism of action of sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The toxicity of metabolites of sodium valproate in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Antiepileptic drug development: II. Anticonvulsant drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of sodium valproate on motor function regulated by the activation of GABA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of branched-chain fatty acids on GABA-degradation and behavior: further evidence for a role of GABA in quasi-morphine abstinence behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Reversal of the anti-conflict action of valproate by various GABA and benzodiazepine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

A comparative study of the pharmacology of inhibitors of GABA-metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate induced changes in GABA metabolism at the subcellular level

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of Inhibitors of GABA Aminotransferase on the Metabolism of GABA in Brain Tissue and Synaptosomal Fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate enhances GABA turnover in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Animal models of intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

New visions in the pharmacology of anticonvulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The role of the piriform cortex in kindling

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of convulsant and anticonvulsant agents on level and metabolism of gamma-aminobutyric acid in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Kinetics of penetration of common antiepileptic drugs into cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous ("controlled release") administration in a model of generalized seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate and its major metabolite E-2-en-valproate induce different effects on behaviour and brain monoamine metabolism in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Increase of human plasma GABA by sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Plasma GABA levels in neurological patients under treatment with valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Is amygdala kindling in rats a model for drug-resistant partial epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Marked increase in anticonvulsant activity but decrease in wet-dog shake behaviour during short-term treatment of amygdala-kindled rats with valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Antiepileptic drug actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Antiepileptic drug mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

In vitro studies into the effect of inhibition of rat brain succinic semialdehyde dehydrogenase on GABA synthesis and degradation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Comparison of the structural characteristics of the 4-aminobutyrate:2-oxoglutarate transaminases from rat and human brain, and of their affinities for certain inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of dipropylacetate on the glycine cleavage enzyme system and glycine levels. A possible experimental approach to non-ketotic hyperglycinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Metabolite levels in brain following experimental seizures: the effects of isoniazid and sodium valproate in cerebellar and cerebral cortical layers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate: Recent Findings and Perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Cyclic nucleotides and nervous system function

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic Acid and Metabolites: Pharmacological and Toxicological Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic Acid-Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Unusual interactions of benzodiazepine receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Changes in Regional Brain Levels of Amino Acid Putative Neurotransmitters After Prolonged Treatment with t he Anticonvulsant Drugs Diphenylhydantoin, Phenobarbitone, Sodium Valproate, Ethosuximide, and Sulthiame in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CA1 hippocampal pyramidal cells maintained 'in vitro'

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

DMCM: A potent convulsive benzodiazepine receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

GABA and mood disorders: a brief review and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of anticonvulsant drugs on (35S)t-butylbicyclophosphorothionate binding in vitro and ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Studies on gamma-aminobutyric acid transport in cobalt experimental epilepsy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Evidence that a GABAergic mechanism influences the development of DOCA-salt hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Differential effects of phenytoin and sodium valproate on seizure-induced changes in gamma-aminobutyric acid and glutamate release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The evaluation and treatment of seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Does antiepileptic drug therapy prevent the development of "chronic" epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Dipropylacetate and Hyperglycinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Anticonvulsant and antiaggressive properties of di-n-propyl acetate after repeated treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of n-di-propylacetate on aggressive behavior and brain GABA level in isolated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Sodium Valproate Increases Potassium Conductance in Aplysia Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of acute and chronic anticonvulsant administration on endogenous gamma-hydroxybutyrate in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

gamma-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Comparison of effects of valproate and trans-2-en-valproate on different forms of epileptiform activity in rat hippocampal and temporal cortex slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Consequence of epileptic activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effect of valproic acid on [3H]diazepam and [3H]dihydropicrotoxinin binding sites at the benzodiazepine-GABA receptor-ionophore complex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Brain microdialysis of GABA and glutamate: what does it signify?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Characterization of extracellular GABA in the substantia nigra reticulata by means of brain microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Guanosine 3'-5'-Monophosphate in the CSF of Neurological Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate and sodium currents in cultured hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate reduces excitability by blockage of sodium and potassium conductance

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Is the anticonvulsant mechanism of valproate linked to its interaction with the cerebral gamma-hydroxybutyrate system?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

The role of GABA in the anticonflict action of sodium valproate and chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of valproate on amino acid and monoamine concentrations in striatum of audiogenic seizure-prone Balb/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of valproate on early and late potassium currents of single neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic acid treatment of experimental status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of the anticonvulsant sodium valproate on gamma-aminobutyrate and aldehyde metabolism in ox brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Effects of anticonvulsants on the formation of gamma-hydroxybutyrate from gamma-aminobutyrate in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproic acid differs in its in vitro effect on glutamic acid decarboxylase activity in neonatal and adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Suppression of preoptic GABA release caused by push-pull-perfusion with sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900075-6

7 January 2021

10.1016/S0301-0082(98)00075-6

Identifiers

DOI

1 reference

release_bbcizxcgpfdh3l3zrekwfoqx6e

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bbcizxcgpfdh3l3zrekwfoqx6e

24 November 2022

mapped directly with Wikidata item

1 reference